カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のプロゲステロン薬物市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Progesterone Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19570）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19570
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：105
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のプロゲステロン薬物市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

プロゲステロン薬物市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のプロゲステロン薬物の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

プロゲステロン薬物市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・カプセル剤、錠剤、その他

用途別セグメントは次のように区分されます。
・病院、診療所、薬局、その他

世界のプロゲステロン薬物市場の主要な市場プレーヤーは以下のとおりです。
・Merck、Pfizer、BionPharma、Teva Pharmaceutical Industries、Aquatic Remedies、Sofgen Pharmaceuticals、Virtus Pharmaceuticals、Intas Pharmaceuticals、Zhejiang Xianju Pharmaceutical、Hubei Dongxin Pharmaceutical、Zhejiang Medicine、Zhejiang Aisheng Pharmaceutical、Beijing Winsunny Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、プロゲステロン薬物製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なプロゲステロン薬物メーカーの企業概要、2019年～2022年までのプロゲステロン薬物の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なプロゲステロン薬物メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別プロゲステロン薬物の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのプロゲステロン薬物の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのプロゲステロン薬物市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびプロゲステロン薬物の産業チェーンを掲載しています。
・第13、14、15章では、プロゲステロン薬物の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- プロゲステロン薬物の概要
- 種類別分析（2017年vs2021年vs2028年）：カプセル剤、錠剤、その他
- 用途別分析（2017年vs2021年vs2028年）：病院、診療所、薬局、その他
- 世界のプロゲステロン薬物市場規模・予測
- 世界のプロゲステロン薬物生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Merck、Pfizer、BionPharma、Teva Pharmaceutical Industries、Aquatic Remedies、Sofgen Pharmaceuticals、Virtus Pharmaceuticals、Intas Pharmaceuticals、Zhejiang Xianju Pharmaceutical、Hubei Dongxin Pharmaceutical、Zhejiang Medicine、Zhejiang Aisheng Pharmaceutical、Beijing Winsunny Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：カプセル剤、錠剤、その他
・用途別分析2017年-2028年：病院、診療所、薬局、その他
・プロゲステロン薬物の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・プロゲステロン薬物のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・プロゲステロン薬物のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・プロゲステロン薬物の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・プロゲステロン薬物の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Progesterone Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Progesterone Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital accounting for % of the Progesterone Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Capsules segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Progesterone Drugs include Merck, Pfizer, BionPharma, Teva Pharmaceutical Industries, and Aquatic Remedies, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Progesterone Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Capsules
Tablets
Others
Market segment by Application can be divided into
Hospital
Clinic
Pharmacy
Other
The key market players for global Progesterone Drugs market are listed below:
Merck
Pfizer
BionPharma
Teva Pharmaceutical Industries
Aquatic Remedies
Sofgen Pharmaceuticals
Virtus Pharmaceuticals
Intas Pharmaceuticals
Zhejiang Xianju Pharmaceutical
Hubei Dongxin Pharmaceutical
Zhejiang Medicine
Zhejiang Aisheng Pharmaceutical
Beijing Winsunny Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Progesterone Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Progesterone Drugs, with price, sales, revenue and global market share of Progesterone Drugs from 2019 to 2022.
Chapter 3, the Progesterone Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Progesterone Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Progesterone Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Progesterone Drugs.
Chapter 13, 14, and 15, to describe Progesterone Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Progesterone Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Progesterone Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Capsules
1.2.3 Tablets
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Progesterone Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.3.5 Other
1.4 Global Progesterone Drugs Market Size & Forecast
1.4.1 Global Progesterone Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Progesterone Drugs Sales in Volume (2017-2028)
1.4.3 Global Progesterone Drugs Price (2017-2028)
1.5 Global Progesterone Drugs Production Capacity Analysis
1.5.1 Global Progesterone Drugs Total Production Capacity (2017-2028)
1.5.2 Global Progesterone Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Progesterone Drugs Market Drivers
1.6.2 Progesterone Drugs Market Restraints
1.6.3 Progesterone Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Progesterone Drugs Product and Services
2.1.4 Merck Progesterone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Progesterone Drugs Product and Services
2.2.4 Pfizer Progesterone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 BionPharma
2.3.1 BionPharma Details
2.3.2 BionPharma Major Business
2.3.3 BionPharma Progesterone Drugs Product and Services
2.3.4 BionPharma Progesterone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Teva Pharmaceutical Industries
2.4.1 Teva Pharmaceutical Industries Details
2.4.2 Teva Pharmaceutical Industries Major Business
2.4.3 Teva Pharmaceutical Industries Progesterone Drugs Product and Services
2.4.4 Teva Pharmaceutical Industries Progesterone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Aquatic Remedies
2.5.1 Aquatic Remedies Details
2.5.2 Aquatic Remedies Major Business
2.5.3 Aquatic Remedies Progesterone Drugs Product and Services
2.5.4 Aquatic Remedies Progesterone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Sofgen Pharmaceuticals
2.6.1 Sofgen Pharmaceuticals Details
2.6.2 Sofgen Pharmaceuticals Major Business
2.6.3 Sofgen Pharmaceuticals Progesterone Drugs Product and Services
2.6.4 Sofgen Pharmaceuticals Progesterone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Virtus Pharmaceuticals
2.7.1 Virtus Pharmaceuticals Details
2.7.2 Virtus Pharmaceuticals Major Business
2.7.3 Virtus Pharmaceuticals Progesterone Drugs Product and Services
2.7.4 Virtus Pharmaceuticals Progesterone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Intas Pharmaceuticals
2.8.1 Intas Pharmaceuticals Details
2.8.2 Intas Pharmaceuticals Major Business
2.8.3 Intas Pharmaceuticals Progesterone Drugs Product and Services
2.8.4 Intas Pharmaceuticals Progesterone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Zhejiang Xianju Pharmaceutical
2.9.1 Zhejiang Xianju Pharmaceutical Details
2.9.2 Zhejiang Xianju Pharmaceutical Major Business
2.9.3 Zhejiang Xianju Pharmaceutical Progesterone Drugs Product and Services
2.9.4 Zhejiang Xianju Pharmaceutical Progesterone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Hubei Dongxin Pharmaceutical
2.10.1 Hubei Dongxin Pharmaceutical Details
2.10.2 Hubei Dongxin Pharmaceutical Major Business
2.10.3 Hubei Dongxin Pharmaceutical Progesterone Drugs Product and Services
2.10.4 Hubei Dongxin Pharmaceutical Progesterone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Zhejiang Medicine
2.11.1 Zhejiang Medicine Details
2.11.2 Zhejiang Medicine Major Business
2.11.3 Zhejiang Medicine Progesterone Drugs Product and Services
2.11.4 Zhejiang Medicine Progesterone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Zhejiang Aisheng Pharmaceutical
2.12.1 Zhejiang Aisheng Pharmaceutical Details
2.12.2 Zhejiang Aisheng Pharmaceutical Major Business
2.12.3 Zhejiang Aisheng Pharmaceutical Progesterone Drugs Product and Services
2.12.4 Zhejiang Aisheng Pharmaceutical Progesterone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Beijing Winsunny Pharmaceutical
2.13.1 Beijing Winsunny Pharmaceutical Details
2.13.2 Beijing Winsunny Pharmaceutical Major Business
2.13.3 Beijing Winsunny Pharmaceutical Progesterone Drugs Product and Services
2.13.4 Beijing Winsunny Pharmaceutical Progesterone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Progesterone Drugs Breakdown Data by Manufacturer
3.1 Global Progesterone Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Progesterone Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Progesterone Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Progesterone Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Progesterone Drugs Manufacturer Market Share in 2021
3.5 Global Progesterone Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Progesterone Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Progesterone Drugs Market Size by Region
4.1.1 Global Progesterone Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Progesterone Drugs Revenue by Region (2017-2028)
4.2 North America Progesterone Drugs Revenue (2017-2028)
4.3 Europe Progesterone Drugs Revenue (2017-2028)
4.4 Asia-Pacific Progesterone Drugs Revenue (2017-2028)
4.5 South America Progesterone Drugs Revenue (2017-2028)
4.6 Middle East and Africa Progesterone Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Progesterone Drugs Sales in Volume by Type (2017-2028)
5.2 Global Progesterone Drugs Revenue by Type (2017-2028)
5.3 Global Progesterone Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Progesterone Drugs Sales in Volume by Application (2017-2028)
6.2 Global Progesterone Drugs Revenue by Application (2017-2028)
6.3 Global Progesterone Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Progesterone Drugs Sales by Type (2017-2028)
7.2 North America Progesterone Drugs Sales by Application (2017-2028)
7.3 North America Progesterone Drugs Market Size by Country
7.3.1 North America Progesterone Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Progesterone Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Progesterone Drugs Sales by Type (2017-2028)
8.2 Europe Progesterone Drugs Sales by Application (2017-2028)
8.3 Europe Progesterone Drugs Market Size by Country
8.3.1 Europe Progesterone Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Progesterone Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Progesterone Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Progesterone Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Progesterone Drugs Market Size by Region
9.3.1 Asia-Pacific Progesterone Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Progesterone Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Progesterone Drugs Sales by Type (2017-2028)
10.2 South America Progesterone Drugs Sales by Application (2017-2028)
10.3 South America Progesterone Drugs Market Size by Country
10.3.1 South America Progesterone Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Progesterone Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Progesterone Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Progesterone Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Progesterone Drugs Market Size by Country
11.3.1 Middle East & Africa Progesterone Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Progesterone Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Progesterone Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Progesterone Drugs
12.3 Progesterone Drugs Production Process
12.4 Progesterone Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Progesterone Drugs Typical Distributors
13.3 Progesterone Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Progesterone Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Progesterone Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Progesterone Drugs Product and Services
Table 6. Merck Progesterone Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Progesterone Drugs Product and Services
Table 10. Pfizer Progesterone Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. BionPharma Basic Information, Manufacturing Base and Competitors
Table 12. BionPharma Major Business
Table 13. BionPharma Progesterone Drugs Product and Services
Table 14. BionPharma Progesterone Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 16. Teva Pharmaceutical Industries Major Business
Table 17. Teva Pharmaceutical Industries Progesterone Drugs Product and Services
Table 18. Teva Pharmaceutical Industries Progesterone Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Aquatic Remedies Basic Information, Manufacturing Base and Competitors
Table 20. Aquatic Remedies Major Business
Table 21. Aquatic Remedies Progesterone Drugs Product and Services
Table 22. Aquatic Remedies Progesterone Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Sofgen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Sofgen Pharmaceuticals Major Business
Table 25. Sofgen Pharmaceuticals Progesterone Drugs Product and Services
Table 26. Sofgen Pharmaceuticals Progesterone Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Virtus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. Virtus Pharmaceuticals Major Business
Table 29. Virtus Pharmaceuticals Progesterone Drugs Product and Services
Table 30. Virtus Pharmaceuticals Progesterone Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Intas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Intas Pharmaceuticals Major Business
Table 33. Intas Pharmaceuticals Progesterone Drugs Product and Services
Table 34. Intas Pharmaceuticals Progesterone Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Zhejiang Xianju Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 36. Zhejiang Xianju Pharmaceutical Major Business
Table 37. Zhejiang Xianju Pharmaceutical Progesterone Drugs Product and Services
Table 38. Zhejiang Xianju Pharmaceutical Progesterone Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Hubei Dongxin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Hubei Dongxin Pharmaceutical Major Business
Table 41. Hubei Dongxin Pharmaceutical Progesterone Drugs Product and Services
Table 42. Hubei Dongxin Pharmaceutical Progesterone Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Zhejiang Medicine Basic Information, Manufacturing Base and Competitors
Table 44. Zhejiang Medicine Major Business
Table 45. Zhejiang Medicine Progesterone Drugs Product and Services
Table 46. Zhejiang Medicine Progesterone Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Zhejiang Aisheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 48. Zhejiang Aisheng Pharmaceutical Major Business
Table 49. Zhejiang Aisheng Pharmaceutical Progesterone Drugs Product and Services
Table 50. Zhejiang Aisheng Pharmaceutical Progesterone Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Beijing Winsunny Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 52. Beijing Winsunny Pharmaceutical Major Business
Table 53. Beijing Winsunny Pharmaceutical Progesterone Drugs Product and Services
Table 54. Beijing Winsunny Pharmaceutical Progesterone Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Global Progesterone Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 56. Global Progesterone Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 57. Market Position of Manufacturers in Progesterone Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 58. Global Progesterone Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 59. Head Office and Progesterone Drugs Production Site of Key Manufacturer
Table 60. Progesterone Drugs New Entrant and Capacity Expansion Plans
Table 61. Progesterone Drugs Mergers & Acquisitions in the Past Five Years
Table 62. Global Progesterone Drugs Sales by Region (2017-2022) & (K Units)
Table 63. Global Progesterone Drugs Sales by Region (2023-2028) & (K Units)
Table 64. Global Progesterone Drugs Revenue by Region (2017-2022) & (USD Million)
Table 65. Global Progesterone Drugs Revenue by Region (2023-2028) & (USD Million)
Table 66. Global Progesterone Drugs Sales by Type (2017-2022) & (K Units)
Table 67. Global Progesterone Drugs Sales by Type (2023-2028) & (K Units)
Table 68. Global Progesterone Drugs Revenue by Type (2017-2022) & (USD Million)
Table 69. Global Progesterone Drugs Revenue by Type (2023-2028) & (USD Million)
Table 70. Global Progesterone Drugs Price by Type (2017-2022) & (US$/Unit)
Table 71. Global Progesterone Drugs Price by Type (2023-2028) & (US$/Unit)
Table 72. Global Progesterone Drugs Sales by Application (2017-2022) & (K Units)
Table 73. Global Progesterone Drugs Sales by Application (2023-2028) & (K Units)
Table 74. Global Progesterone Drugs Revenue by Application (2017-2022) & (USD Million)
Table 75. Global Progesterone Drugs Revenue by Application (2023-2028) & (USD Million)
Table 76. Global Progesterone Drugs Price by Application (2017-2022) & (US$/Unit)
Table 77. Global Progesterone Drugs Price by Application (2023-2028) & (US$/Unit)
Table 78. North America Progesterone Drugs Sales by Country (2017-2022) & (K Units)
Table 79. North America Progesterone Drugs Sales by Country (2023-2028) & (K Units)
Table 80. North America Progesterone Drugs Revenue by Country (2017-2022) & (USD Million)
Table 81. North America Progesterone Drugs Revenue by Country (2023-2028) & (USD Million)
Table 82. North America Progesterone Drugs Sales by Type (2017-2022) & (K Units)
Table 83. North America Progesterone Drugs Sales by Type (2023-2028) & (K Units)
Table 84. North America Progesterone Drugs Sales by Application (2017-2022) & (K Units)
Table 85. North America Progesterone Drugs Sales by Application (2023-2028) & (K Units)
Table 86. Europe Progesterone Drugs Sales by Country (2017-2022) & (K Units)
Table 87. Europe Progesterone Drugs Sales by Country (2023-2028) & (K Units)
Table 88. Europe Progesterone Drugs Revenue by Country (2017-2022) & (USD Million)
Table 89. Europe Progesterone Drugs Revenue by Country (2023-2028) & (USD Million)
Table 90. Europe Progesterone Drugs Sales by Type (2017-2022) & (K Units)
Table 91. Europe Progesterone Drugs Sales by Type (2023-2028) & (K Units)
Table 92. Europe Progesterone Drugs Sales by Application (2017-2022) & (K Units)
Table 93. Europe Progesterone Drugs Sales by Application (2023-2028) & (K Units)
Table 94. Asia-Pacific Progesterone Drugs Sales by Region (2017-2022) & (K Units)
Table 95. Asia-Pacific Progesterone Drugs Sales by Region (2023-2028) & (K Units)
Table 96. Asia-Pacific Progesterone Drugs Revenue by Region (2017-2022) & (USD Million)
Table 97. Asia-Pacific Progesterone Drugs Revenue by Region (2023-2028) & (USD Million)
Table 98. Asia-Pacific Progesterone Drugs Sales by Type (2017-2022) & (K Units)
Table 99. Asia-Pacific Progesterone Drugs Sales by Type (2023-2028) & (K Units)
Table 100. Asia-Pacific Progesterone Drugs Sales by Application (2017-2022) & (K Units)
Table 101. Asia-Pacific Progesterone Drugs Sales by Application (2023-2028) & (K Units)
Table 102. South America Progesterone Drugs Sales by Country (2017-2022) & (K Units)
Table 103. South America Progesterone Drugs Sales by Country (2023-2028) & (K Units)
Table 104. South America Progesterone Drugs Revenue by Country (2017-2022) & (USD Million)
Table 105. South America Progesterone Drugs Revenue by Country (2023-2028) & (USD Million)
Table 106. South America Progesterone Drugs Sales by Type (2017-2022) & (K Units)
Table 107. South America Progesterone Drugs Sales by Type (2023-2028) & (K Units)
Table 108. South America Progesterone Drugs Sales by Application (2017-2022) & (K Units)
Table 109. South America Progesterone Drugs Sales by Application (2023-2028) & (K Units)
Table 110. Middle East & Africa Progesterone Drugs Sales by Region (2017-2022) & (K Units)
Table 111. Middle East & Africa Progesterone Drugs Sales by Region (2023-2028) & (K Units)
Table 112. Middle East & Africa Progesterone Drugs Revenue by Region (2017-2022) & (USD Million)
Table 113. Middle East & Africa Progesterone Drugs Revenue by Region (2023-2028) & (USD Million)
Table 114. Middle East & Africa Progesterone Drugs Sales by Type (2017-2022) & (K Units)
Table 115. Middle East & Africa Progesterone Drugs Sales by Type (2023-2028) & (K Units)
Table 116. Middle East & Africa Progesterone Drugs Sales by Application (2017-2022) & (K Units)
Table 117. Middle East & Africa Progesterone Drugs Sales by Application (2023-2028) & (K Units)
Table 118. Progesterone Drugs Raw Material
Table 119. Key Manufacturers of Progesterone Drugs Raw Materials
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Progesterone Drugs Typical Distributors
Table 123. Progesterone Drugs Typical Customers
List of Figures
Figure 1. Progesterone Drugs Picture
Figure 2. Global Progesterone Drugs Revenue Market Share by Type in 2021
Figure 3. Capsules
Figure 4. Tablets
Figure 5. Others
Figure 6. Global Progesterone Drugs Revenue Market Share by Application in 2021
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Pharmacy
Figure 10. Other
Figure 11. Global Progesterone Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Progesterone Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Progesterone Drugs Sales (2017-2028) & (K Units)
Figure 14. Global Progesterone Drugs Price (2017-2028) & (US$/Unit)
Figure 15. Global Progesterone Drugs Production Capacity (2017-2028) & (K Units)
Figure 16. Global Progesterone Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Progesterone Drugs Market Drivers
Figure 18. Progesterone Drugs Market Restraints
Figure 19. Progesterone Drugs Market Trends
Figure 20. Global Progesterone Drugs Sales Market Share by Manufacturer in 2021
Figure 21. Global Progesterone Drugs Revenue Market Share by Manufacturer in 2021
Figure 22. Progesterone Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Progesterone Drugs Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Progesterone Drugs Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Progesterone Drugs Sales Market Share by Region (2017-2028)
Figure 26. Global Progesterone Drugs Revenue Market Share by Region (2017-2028)
Figure 27. North America Progesterone Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Europe Progesterone Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Progesterone Drugs Revenue (2017-2028) & (USD Million)
Figure 30. South America Progesterone Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Progesterone Drugs Revenue (2017-2028) & (USD Million)
Figure 32. Global Progesterone Drugs Sales Market Share by Type (2017-2028)
Figure 33. Global Progesterone Drugs Revenue Market Share by Type (2017-2028)
Figure 34. Global Progesterone Drugs Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Progesterone Drugs Sales Market Share by Application (2017-2028)
Figure 36. Global Progesterone Drugs Revenue Market Share by Application (2017-2028)
Figure 37. Global Progesterone Drugs Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Progesterone Drugs Sales Market Share by Type (2017-2028)
Figure 39. North America Progesterone Drugs Sales Market Share by Application (2017-2028)
Figure 40. North America Progesterone Drugs Sales Market Share by Country (2017-2028)
Figure 41. North America Progesterone Drugs Revenue Market Share by Country (2017-2028)
Figure 42. United States Progesterone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Progesterone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Progesterone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Progesterone Drugs Sales Market Share by Type (2017-2028)
Figure 46. Europe Progesterone Drugs Sales Market Share by Application (2017-2028)
Figure 47. Europe Progesterone Drugs Sales Market Share by Country (2017-2028)
Figure 48. Europe Progesterone Drugs Revenue Market Share by Country (2017-2028)
Figure 49. Germany Progesterone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Progesterone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Progesterone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Progesterone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Progesterone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Progesterone Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Progesterone Drugs Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Progesterone Drugs Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Progesterone Drugs Revenue Market Share by Region (2017-2028)
Figure 58. China Progesterone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Progesterone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Progesterone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Progesterone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Progesterone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Progesterone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Progesterone Drugs Sales Market Share by Type (2017-2028)
Figure 65. South America Progesterone Drugs Sales Market Share by Application (2017-2028)
Figure 66. South America Progesterone Drugs Sales Market Share by Country (2017-2028)
Figure 67. South America Progesterone Drugs Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Progesterone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Progesterone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Progesterone Drugs Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Progesterone Drugs Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Progesterone Drugs Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Progesterone Drugs Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Progesterone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Progesterone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Progesterone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Progesterone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Progesterone Drugs in 2021
Figure 79. Manufacturing Process Analysis of Progesterone Drugs
Figure 80. Progesterone Drugs Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • プロゲステロン薬のグローバル市場展望 2023年-2029年：カプセル、錠剤、その他
  • 世界の婦人科用プロゲスチン薬物市場2022年：市場規模予測（～2028年）
  • 世界のプロゲステロンAPI市場2022年：市場規模予測（～2028年）
  • 世界のドルテグラビル＆ドルテグラビルジェネリック医薬品市場2022年：市場規模予測（～2028年）
  • 夜尿症治療薬のグローバル市場展望 2023年-2029年：抗コリン薬、三環系抗うつ薬、デスモプレシン
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19570 )"世界のプロゲステロン薬物市場2022年：市場規模予測（～2028年）" (英文：Global Progesterone Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。